Summary
Radioimmunotherapy has evolved from an attractive concept to implementation in clinical trials for evaluation of toxicity and efficacy. Non-Hodgkin’s lymphoma is a useful setting for evaluation of this novel form of therapy. Groups investigating radioimmunotherapy for non-Hodgkin’s lymphoma are implementing single high doses and multiple smaller doses of beta emitters I-131 and Y-90 attached to antibodies. All groups giving multiple small doses observe partial responses to treatment with variable hematopoietic toxicity. Single very high doses have yielded complete responses with hematologic toxicity requiring reinfusion of stored bone marrow. A review of radioimmunotherapy trials for non-Hodgkin’s lymphoma with a discussion of pertinent related issues is presented.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eary JF, Press OW, Badger CC, Durack L, Richter KY, Krohn KA, Fisher D, Porter B, Williams D, Martin P, Appelbaum FR, Levy R, Brown S, Miller R, Nelp W, Bernstein ID. Imaging and treatment of B-cell lymphoma. J Nucl Med 1990; 31: 1257–1268.
Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp W, Krohn K, Fisher D, DeSantes K, Porter B, Kidd P, Thomas ED, Bernstein ID. Treatment of refractory non-Hodgkin’s lymphoma with radio-labeled MB-1 (Anti-CD37) antibody. J Clin Onc 1989; 7: (8) 1027–1038.
DeNardo GL, DeNardo SJ, O’Grady LF, Lewis JP, Mills SL, Macey DJ, Epstein AL. Treatment of chronic lymphocytic leukemia (CLL) with I-131 LYM-1. J Nucl Med 1989; 30: (5) 827–828.
DeNardo SJ, DeNardo GL, Macey DJ, Mills SL, O’Grady LF, McGahan JP, Epstien AL. Successful radioimmunotherapy in patients with lymphoma: results of dose fractionation of I-131 LYM-1 MoAb. J Nude Med 1988; 29: (5) 847.
Sharkey RM, Horowitz JA, Stein R, Belisle EH, Hansen HJ, Pinsky CM, Hall TC, Goldenberg DM. Tumor targeting and radioimmunotherapy (RAIT) of B-cell lymphoma with a new monoclonal antibody (MAb), EPB-2. Antibody Immunoconjugates, and Radiopharmaceuticals 1990; 3: (1) 53.
Kaminski MS, Fig L, Del Rosario R, Miller R, Buchsbaum D, Mudgett E, Wahl RL. Radioimmunotherapy of advanced B-cell lymphoma with none bone marrow ablative doses of 131-I MB-1 antibody. Antibody Immunoconjugates, and Radiopharmaceuticals 1990; 3: (1) 58.
Halpern S, Parker BA, Vassos A, Frincke J, Amox D, Miller R, Green MR, Royston I. 90 Yttrium (90Y) anti-idiotype monoclonal antibody therapy of non-Hodgkin’s lymphoma. J Nucl Med 1989; 30: (5) 778.
Eary JF, Krohn KA, Kishore RA, Nelp WB. Radiochemistry of halogenated antibodies. In: Zalutsky MR (ed). Antibodies in Radiodiagnosis and Therapy. Boca Raton, Florida, CRC Press; 1989; 83–102.
Deshpande SV, De Nardo SJ, Kukis DL, Moi MM, McCall MJ, DeNardo GL, Meares CE Yttrium-90 labeled monoclonal antibody for therapy: Labeling by a new macrocyclic bifunctional chelating agent. J Nucl Med 1990; 31: 473–479.
Kalades PM, Khazaeli MB, Hazzard E, Vanderbegt DL, LoBuglio AF, Gilman SC. Detection of human anti-murine antibody (HAMA) following infusion of onciscint CR103. Comparison of Elisa with a double antigen radiometric assay. Antibody Immunoconjugates, and Radiopharmaceuticals 1990; 3: (1) 54.
Zimmer AM, Kuzel T, Duda RB, Webber DI, Spies WG, Gilyon K, Samuelson E, Spies SM, Rosen ST. Radioimmunotherapy retreatment of patients with HAMA: effect of cold antibody titration on the pharmacokinetics of radiolabeled antibodies. Antibody Immunoconjugates, and Radiopharmaceuticals. 1990; 3: (1) 53.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Eary, J.E. (1991). Radioimmunotherapy of B-cell lymphoma. In: Ultmann, J.E., Samuels, B.L. (eds) Annals of Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7305-4_30
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7305-4_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7294-1
Online ISBN: 978-1-4899-7305-4
eBook Packages: Springer Book Archive